Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities, especially using QIAcuity digital PCR
Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research
The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow
QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions
New agreement brings leaders in biomedical knowledge solutions and knowledge graph technologies together to aid the biopharmaceutical industry in analytics-driven drug discovery
QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission
QIAcuityDx provides highly precise, absolute quantitation of target DNA and RNA, making it an ideal tool for monitoring cancer progression
QIAGEN and Eli Lilly collaboration set to launch the first commercially available IVD Kit for APOE genotyping
NeuMoDx CT/NG Assay, designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the US
Accelerating DNA library pooling for high-quality next-generation sequencing results
QCI Interpret selected to support Denmark's whole-genome sequencing program
Discover enzymes and applications to catalyze your research success
The artus® SARS-CoV-2 Prep&Amp UM cuts PCR processing times by two thirds
The easy-to-use workflow can detect T-cell response early in the course of COVID-19 infection or following vaccination
The assays have shown efficacy against the newest variants of concern
Newly launched PAXgene Saliva Collector stabilizes collected sample to avoid preanalytical errors and thereby increases reproducibility and reliability of results
QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes
Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases
Solutions combine liquid-based sample preparation with PCR detection and Sanger sequencing
